Multistate marijuana firm iAnthus Capital agreed to acquire the U.S. assets of Toronto-based cannabis company MPX Bioceutical Corp. in an all-stock deal valued at 835 million Canadian dollars ($640 million), the second mega-acquisition in the American MJ industry in less than a week.
US cannabis firm iAnthus inks CA$835 million acquisition of MPX Bioceutical is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Read More: US cannabis firm iAnthus inks CA5 million acquisition of MPX Bioceutical
Comments are closed, but trackbacks and pingbacks are open.